No marked increase in gonorrhoea resistance in doxyPEP study
‘Real world’ injectable treatment halves patient dissatisfaction, with only two viral failures in first six months
Low-level HIV and viral load blips are important warning signals, European study finds
Are people with a shorter history of viral suppression at greater risk of failure of dolutegravir/lamivudine?
Dolutegravir resistance showing up after prolonged periods on failing treatment
High levels of infant resistance to abacavir and tenofovir in Namibia
Broadly neutralising antibody treatment: is pre-existing resistance its Achilles heel?
Injected PrEP: breakthrough cases could have been detected sooner
Point-of-care viral load tests did not improve viral suppression in Kenyan children
